Analgesia After Cesarean Section

Completed

• Conditions: Preeclampsia; Pregnancy
• Interventions: Drug: Magnesium Sulphate

• Registration Number: NCT01360060
• Lead Sponsor: Seoul National University Bundang Hospital

Brief Summary

Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-12
• Primary Completion: 2011-03
• Study Completion: 2011-03
• Status Verified: 2011-05
• Study First Submitted: 2011-05-17
• Study First Submitted QC: 2011-05-24
• Last Update Submitted: 2011-05-24
• Study First Posted: 2011-05-25
• Last Update Posted: 2011-05-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 503

Inclusion Criteria

• parturients undergoing Cesarean section

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Group P	Magnesium Sulphate	parturients who had undergone Cesarean section under the diagnosis of preeclampsia

Primary Outcome Measures

Name	Time	Method
Change of numeric rating scale (NRS) of postoperative pain during postoperative period	postoperative 1, 2, 3, and 4 day

Secondary Outcome Measures

Name	Time	Method
incidence of stopping of intravenous PCA during postoperative 4 days	during postoperative 4 days
serum magnesium level of group P	preoperative 1 h and postoperative 1 day

Trial Locations

Locations (1)

Seoul national university bundang hospital; 🇰🇷 Seongnam, Gyeonggi, Korea, Republic of